__
Pear gets FDA clearance for insomnia therapeutic (MedCity News):
“Pear Therapeutics received marketing authorization for its third product — a digital therapeutic intended to treat chronic insomnia. Called Somryst, the app is available by prescription only. It consists of a nine-week program that includes cognitive behavioral therapy and restricting sleep to a limited window of time [Read more…] about The FDA clears Somryst, Pear’s digital therapeutic to treat chronic insomnia